Please ensure Javascript is enabled for purposes of website accessibility

The Nod from Nasdaq

Biz BriefsSavient Pharmaceuticals has received notification from the Nasdaq Listings Qualification Panel that it will continue to be listed as a public company on the Nasdaq National Market. Its status on the Nasdaq— traded under the symbol SVNT—had come into question last year because of its failure to file two quarterly reports for 2005, amendments to a 2005 quarterly report and its annual report for 2004 with the Securities and Exchange Commission. The East Brunswick-based specialty pharmaceutical company had asked for extensions on all four filings.

NJBIZ Business Events

NJBIZ Healthcare Heroes 2022

Wednesday, August 10, 2022
NJBIZ Healthcare Heroes 2022

NJBIZ Connect Networking Event

Tuesday, September 13, 2022
NJBIZ Connect Networking Event

NJBIZ Forty Under 40 Awards 2022

Wednesday, September 21, 2022
NJBIZ Forty Under 40 Awards 2022